---
schema_version: "secwatch.filing_event.v1"
accession: "0001062993-24-008068"
form_type: "8-K"
ticker: null
cik: "0001617765"
company_name: "EVOME MEDICAL TECHNOLOGIES INC."
filed_at: "2024-04-04T23:59:59+00:00"
generated_at: "2026-06-04T02:19:34.034420+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Evome sells Simbex R&D unit to Riddell for $3.55M cash; proceeds cut acquisition debt

## Summary
- Sale price $3.55M (~$4.83M CAD) cash for Simbex LLC to EB Sports Corp (Riddell parent).
- Proceeds reduce Simbex senior debt by ~$824k and Biodex acquisition debt by ~$2.12M.
- Annual revenue to decline ~$6M but net income impact immaterial; balance sheet strengthened.
- CEO notes two consecutive quarters of positive Adjusted EBITDA; expects 'breakout' Q2 for Biodex.
- New products: RST (Reactive Step Trainer) launched Feb 2024; SpaceTek Knee planned late 2024.

## SEC filing metadata
- accession: 0001062993-24-008068
- form_type: 8-K
- cik: 0001617765
- company_name: EVOME MEDICAL TECHNOLOGIES INC.
- filed_at: 2024-04-04T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1617765/000106299324008068/0001062993-24-008068-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1617765/000106299324008068/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062993-24-008068
- JSON: https://secwatch.observer/filing/0001062993-24-008068.json
- Plain text: https://secwatch.observer/filing/0001062993-24-008068.txt

## Key facts
- M&A Transactions
  EVOME MEDICAL TECHNOLOGIES INC. completed a disposition involving EB Sports Corp. for $3,550,000 (closed 2024-04-01).
  - Action: disposition
  - Counterparty: EB Sports Corp.
  - Consideration: $3,550,000
  - Closing: 2024-04-01
  source text: the Purchaser agreed to purchase from the Seller all of the issued and outstanding membership interests owned by the Seller in Simbex LLC, a Delaware limited liability company (the " Membership Interests ") for a purchase price of $3,550,000
  evidence_url: https://www.sec.gov/Archives/edgar/data/1617765/000106299324008068/0001062993-24-008068-index.htm
- Material Agreements
  EVOME MEDICAL TECHNOLOGIES INC. entered into Purchase Agreement with EB Sports Corp. valued at $3,550,000 (effective 2024-04-01).
  - Action: entry
  - Agreement: asset purchase
  - Counterparty: EB Sports Corp.
  - Value: $3,550,000
  - Effective: 2024-04-01
  source text: On April 1, 2024, Evome Medical Technologies Inc., a British Columbia corporation (the " Company "), its wholly-owned subsidiary Simbex Acquisition I Corporation, a Delaware corporation (" Seller "), and EB Sports Corp., a Delaware corporation (the " Purchaser "), entered into a membership interest purchase agreement (the " Purchase Agreement "), pursuant to which the Purchaser agreed to purchase from the Seller all of the issued and outstanding membership interests owned by the Seller in Simbex LLC, a Delaware limited liability company (the " Membership Interests ") for a purchase price of $3,550,000, subject to certain adjustments for working capital, indebtedness, and transaction expenses.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1617765/000106299324008068/0001062993-24-008068-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.